Aspiration thrombectomy and intracoronary tirofiban in ST-segment elevation myocardial infarction: Combination treatment for patients undergoing primary percutaneous coronary intervention;Aspirationsthrombektomie und intrakoronare Tirofibangabe bei ST-Hebungs-Infarkt: Kombinationstherapie bei Patienten mit primärer perkutaner Koronarintervention

Herz

Volumn 41, Issue 8, 2016, Pages 732-740

  Geng, T ^a   Zhang, J G ^a   Song, Z Y ^a   Dai, S P ^a   Luo, Y ^a   Xu, Z S ^a  

^a The Second Department of Cangzhou Cardiovascular Institute   (China)

Author keywords

Aspiration thrombectomy; Intracoronary tirofiban; Myocardial infarction; Percutaneous coronary intervention; Platelet glycoprotein IIb IIIa receptor antagonist

Indexed keywords

TIROFIBAN; FIBRINOLYTIC AGENT; TYROSINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPISTAXIS; FEMALE; GINGIVA BLEEDING; HEART INFARCTION; HEART INFARCTION SIZE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; ANALOGS AND DERIVATIVES; CHINA; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; UTILIZATION;

CHINA; COMBINED MODALITY THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; TYROSINE;

EID: 84976629699     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-016-4426-4     Document Type: Article

References (42)

1. Romano M, Buffoli F, Lettieri C, Aroldi M, Tomasi L, Baccaglioni N et al (2005) No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and predictive factors. Minerva Cardioangiol 53(1):7–14
2. Eeckhout E, Kern MJ (2001) The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 22(9):729–739
3. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D et al (2006) Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355(11):1093–1104
4. Henriques JP, Zijlstra F, Ottervanger JP, Boer MJ de, Hof AW van’t, Hoorntje JC, Suryapranata H (2002) Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23(14):1112–1117
5. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S et al (1996) Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93(11):1993–1999
6. Brener SJ, Cristea E, Mehran R, Dressler O, Lansky AJ, Stone GW (2011) Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revascularization and stents in AMI (HORIZONS-AMI) trial. Am Heart J 162(6):1044–1051
7. Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E et al (2008) Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118(1):49–57
8. Luca G De, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F (2008) Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 29(24):3002–3010
9. Inaba Y, Chen JA, Mehta N, Bergmann SR (2009) Impact of single or multicentre study design on the results of trials examining the efficacy of adjunctive devices to prevent distal embolisation during acute myocardial infarction. EuroIntervention 5(3):375–383
10. Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL et al (2010) Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Circulation 122(25):2709–2717
11. Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R et al (2011) Rationale and design of the INFUSE-AMI study: A 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J 161(3):478–486
12. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al (2014) A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol 63(20):2088–2098
13. Luca G De, Verdoia M, Suryapranata H (2012) Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. Atherosclerosis 222(2):426–433
14. Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379(9819):923–931
15. Piccolo R, Eitel I, Iversen AZ, Gu YL, Dominguez-Rodriguez A, Smet BJ de et al (2014) Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials. EuroIntervention 9(9):1110–1120
16. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 122(4):1322–1332
17. Hara M, Saikawa T, Tsunematsu Y, Sakata T, Yoshimatsu H (2005) Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction. J Atheroscler Thromb 12(6):315–321
18. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the american college of cardiology foundation/american heart association task force on practice guidelines and the society for cardiovascular Angiography and interventions. Circulation 124(23):574–651
19. Stone GW, Dixon SR, Grines CL, Cox DA, Webb JG, Brodie BR et al (2007) Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 100(9):1370–1375
20. Hof AW van’t, Liem A, Suryapranata H, Hoorntje JC, Boer MJ de, Zijlstra F, Zwolle Myocardial Infarction Study Group (1998) Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97(23):2302–2306
21. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D et al (2002) No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105(18):2148–2152
22. Burzotta F, Trani C, Romagnoli E, Belloni F, Biondi-Zoccai GG, Mazzari MA et al (2006) A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study. Catheter Cardiovasc Interv 67(6):887–893
23. Svilaas T, Vlaar PJ, Horst IC van der, Diercks GF, Smet BJ de, Heuvel AF van den et al (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358(6):557–567
24. Vlaar PJ, Svilaas T, Horst IC van der, Diercks GF, Fokkema ML, Smet BJ de et al (2008) Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1‑year follow-up study. Lancet 371(9628):1915–1920
25. Sardella G, Mancone M, Canali E, Roma A Di, Benedetti G, Stio R et al (2010) Impact of thrombectomy with EXPort Catheter in Infarct-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac death. Am J Cardiol 106(5):624–629
26. Burzotta F, Vita M De, Gu YL, Isshiki T, Lefevre T, Kaltoft A et al (2009) Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J 30(18):2193–2203
27. Kini AS, Chen VH, Krishnan P, Lee P, Kim MC, Mares A et al (2008) Bolus-only versus bolus + infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. Am Heart J 156(3):513–519
28. Mehilli J, Kastrati A, Schulz S, Frungel S, Nekolla SG, Moshage W et al (2009) Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 119(14):1933–1940
29. Auffret V, Oger E, Leurent G, Filippi E, Coudert I, Hacot JP et al (2014) Efficacy of pre-hospital use of glycoprotein IIb/IIIa inhibitors in ST-segment elevation myocardial infarction before mechanical reperfusion in a rapid-transfer network (from the Acute Myocardial Infarction Registry of Brittany). Am J Cardiol 114(2):214–223
30. Zhu TQ, Zhang Q, Qiu JP, Jin HG, Lu L, Shen J et al (2013) Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study. Int J Cardiol 165(3):437–443
31. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619
32. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, Lemos JA de et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 61(4):485–510
33. Romagnoli E, Burzotta F, Trani C, Biondi-Zoccai GG, Giannico F, Crea F (2007) Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis 23(1):57–63
34. Kubica A, Kozinski M, Navarese EP, Grzesk G, Goch A, Kubica J (2011) Intracoronary versus intravenous abciximab administration in STEMI patients: overview of current status and open questions. Curr Med Res Opin 27(11):2133–2144
35. Navarese EP, Kozinski M, Obonska K, Margheri M, Gurbel PA, Kubica J, Luca G De (2012) Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials. Platelets 23(4):274–281
36. Shimada YJ, Nakra NC, Fox JT, Kanei Y (2012) Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 109(5):624–628
37. Kandzari DE, Hasselblad V, Tcheng JE, Stone GW, Califf RM, Kastrati A et al (2004) Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J 147(3):457–462
38. Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH et al (2012) Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 307(17):1817–1826
39. Ahn SG, Lee SH, Lee JH, Lee JW, Youn YJ, Ahn MS et al (2014) Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. Yonsei Med J 55(3):606–616
40. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A et al (2005) Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293(9):1063–1072
41. Yan HB, Li SY, Song L, Wang J, Wu Z, Chi YP et al (2010) Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction. Chin Med J 123(7):877–883
42. Li SY, Yan HB, Wang J, Song L, Wu Z, Chi YP et al (2010) Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty. Zhonghua Xin Xue Guan Bing Za Zhi 38(10):880–885